1. Home
  2. BOLD vs HKIT Comparison

BOLD vs HKIT Comparison

Compare BOLD & HKIT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOLD
  • HKIT
  • Stock Information
  • Founded
  • BOLD 2018
  • HKIT 1996
  • Country
  • BOLD United States
  • HKIT China
  • Employees
  • BOLD N/A
  • HKIT N/A
  • Industry
  • BOLD
  • HKIT Computer Software: Prepackaged Software
  • Sector
  • BOLD
  • HKIT Technology
  • Exchange
  • BOLD Nasdaq
  • HKIT Nasdaq
  • Market Cap
  • BOLD 49.5M
  • HKIT 45.4M
  • IPO Year
  • BOLD 2024
  • HKIT 2023
  • Fundamental
  • Price
  • BOLD $1.96
  • HKIT $1.26
  • Analyst Decision
  • BOLD Buy
  • HKIT
  • Analyst Count
  • BOLD 3
  • HKIT 0
  • Target Price
  • BOLD $22.50
  • HKIT N/A
  • AVG Volume (30 Days)
  • BOLD 50.0K
  • HKIT 23.4K
  • Earning Date
  • BOLD 04-03-2025
  • HKIT 04-08-2025
  • Dividend Yield
  • BOLD N/A
  • HKIT N/A
  • EPS Growth
  • BOLD N/A
  • HKIT N/A
  • EPS
  • BOLD N/A
  • HKIT 0.04
  • Revenue
  • BOLD N/A
  • HKIT $3,449,206.00
  • Revenue This Year
  • BOLD N/A
  • HKIT N/A
  • Revenue Next Year
  • BOLD N/A
  • HKIT N/A
  • P/E Ratio
  • BOLD N/A
  • HKIT $33.13
  • Revenue Growth
  • BOLD N/A
  • HKIT N/A
  • 52 Week Low
  • BOLD $1.95
  • HKIT $1.00
  • 52 Week High
  • BOLD $15.24
  • HKIT $2.35
  • Technical
  • Relative Strength Index (RSI)
  • BOLD N/A
  • HKIT 46.17
  • Support Level
  • BOLD N/A
  • HKIT $1.23
  • Resistance Level
  • BOLD N/A
  • HKIT $1.34
  • Average True Range (ATR)
  • BOLD 0.00
  • HKIT 0.08
  • MACD
  • BOLD 0.00
  • HKIT 0.00
  • Stochastic Oscillator
  • BOLD 0.00
  • HKIT 57.89

About BOLD Boundless Bio Inc. Common Stock

Boundless Bio Inc is a clinical-stage oncology company. It is dedicated to unlocking a new paradigm in cancer therapeutics that addresses the significant unmet need in patients with oncogene amplified tumors by targeting extrachromosomal DNA (ecDNA), a root cause of oncogene amplification observed in more than 14% of cancer patients. Its ecDTx, BBI-355, is a novel, oral, selective inhibitor of checkpoint kinase 1 (CHK1), which manages ecDNA replication and transcription in cancer cells.

About HKIT Hitek Global Inc.

Hitek Global Inc is a provider of information technology consulting and solutions services. The company has two lines of businesses such as services to small and medium businesses, which consist of Anti-Counterfeiting Tax Control System tax devices, including Golden Tax Disk and printers, ACTCS services, and IT services; and services to large businesses, which include hardware sales and software sales. It generates revenues from hardware sales, software sales, IT services, and tax devices and services.

Share on Social Networks: